Written question asked by Bell Ribeiro-Addy (Labour) on Tuesday, 2 September 2025, in the House of Commons. It was due for an answer on Monday, 8 September 2025 (named day). A holding answer was provided on Tuesday, 9 September 2025. A substantive answer was provided by Ashley Dalton (Labour) on Monday, 29 September 2025 on behalf of the Department of Health and Social Care.

Sickle Cell Diseases: Medical Treatments

Question: To ask the Secretary of State for Health and Social Care, what recent discussions he has had with the NHS on its policy of informing Sickle Cell patients when they are not given Ro matched blood.

Answer: DHSC are working in partnership with NHS Blood and Transplant, NHS England and the National Blood Transfusion Committee to deliver on the recommendations detailed in the infected blood inquiry, which includes improving digital patient records and communications for patients receiving transfusions. A blood genotyping programme has also been introduced, enabling detection of previously undetectable antibodies that could cause complications. To meet the clinical need to provide better matched blood for patients with conditions like sickle cell disorder, NHS Blood and Transplant is actively recruiting donors from Black heritage backgrounds.

Secondary information